Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-7-22
pubmed:abstractText
Blockade of CD40 ligand (CD40L; CD154, gp39) is a potential treatment for autoimmune disease and allograft rejection. However, CD40L-/- mice are capable of mobilizing cellular immune responses to viral, parasitic, and intracellular bacterial infections as well as rejecting skin grafts with nearly the same efficiency as wild-type mice. CD40L-deficient mice (CD40L-/-) or wild-type mice treated with anti-CD40L develop chronic vasculopathy only 8 weeks after allogeneic heart transplantation. To overcome CD40L-independent immune responses, we used anti-lymphocyte function-associated antigen monoclonal antibody (LFA)-1, which has previously been shown to inhibit CD8+ immune responses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-41
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12134096-Animals, pubmed-meshheading:12134096-Antibodies, Monoclonal, pubmed-meshheading:12134096-CD40 Ligand, pubmed-meshheading:12134096-Cell Division, pubmed-meshheading:12134096-Chronic Disease, pubmed-meshheading:12134096-Graft Rejection, pubmed-meshheading:12134096-Graft Survival, pubmed-meshheading:12134096-Heart Transplantation, pubmed-meshheading:12134096-Male, pubmed-meshheading:12134096-Mice, pubmed-meshheading:12134096-Mice, Inbred BALB C, pubmed-meshheading:12134096-Mice, Inbred C3H, pubmed-meshheading:12134096-Mice, Inbred C57BL, pubmed-meshheading:12134096-Mice, Knockout, pubmed-meshheading:12134096-Postoperative Complications, pubmed-meshheading:12134096-Skin Transplantation, pubmed-meshheading:12134096-T-Lymphocytes, Cytotoxic, pubmed-meshheading:12134096-Transplantation, Homologous, pubmed-meshheading:12134096-Vascular Diseases
pubmed:year
2002
pubmed:articleTitle
Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
pubmed:affiliation
Department of Nephrology and Transplantation, University Hospital, Lund University, Malmö, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't